• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有代谢拮抗作用的氟达拉滨与钯和铂的配合物,对肿瘤细胞具有显著高于非恶性细胞的选择性。

Palladium and Platinum Complexes of the Antimetabolite Fludarabine with Vastly Enhanced Selectivity for Tumour over Non-Malignant Cells.

机构信息

Organic Chemistry Laboratory, University Bayreuth, Universitaetsstrasse 30, 95447 Bayreuth, Germany.

University Clinic for Internal Medicine IV, Hematology/Oncology, Medical Faculty, Martin Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle, Germany.

出版信息

Molecules. 2023 Jul 2;28(13):5173. doi: 10.3390/molecules28135173.

DOI:10.3390/molecules28135173
PMID:37446835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10343763/
Abstract

The purine derivative fludarabine is part of frontline therapy for chronic lymphocytic leukaemia (CLL). It has shown positive effects on solid tumours such as melanoma, breast, and colon carcinoma in clinical phase I studies. As the treatment of CLL cells with combinations of fludarabine and metal complexes of antitumoural natural products, e.g., illudin M ferrocene, has led to synergistically enhanced apoptosis, in this research study different complexes of fludarabine itself. Four complexes bearing a -[Br(PPh)]Pt/Pd fragment attached to atom C-8 via formal η-sigma or η-carbene bonds were synthesised in two or three steps without protecting polar groups on the arabinose or adenine. The platinum complexes were more cytotoxic than their palladium analogues, with low single-digit micromolar IC values against cells of various solid tumour entities, including cisplatin-resistant ones and certain B-cell lymphoma and CLL, presumably due to the ten-fold higher cellular uptake of the platinum complexes. However, the palladium complexes interacted more readily with isolated Calf thymus DNA. Interestingly, the platinum complexes showed vastly greater selectivity for cancer over non-malignant cells when compared with fludarabine.

摘要

嘌呤衍生物氟达拉滨是慢性淋巴细胞白血病(CLL)一线治疗的一部分。在 I 期临床试验中,它已显示出对黑色素瘤、乳腺癌和结肠癌等实体瘤的积极作用。由于用氟达拉滨和抗肿瘤天然产物的金属配合物(如艾鲁丁 M 二茂铁)联合治疗 CLL 细胞导致协同增强的细胞凋亡,因此在这项研究中,我们合成了不同的氟达拉滨自身配合物。通过正式的 η-σ 或 η-卡宾键,将 -[Br(PPh)]Pt/Pd 片段连接到通过原子 C-8 的阿拉伯糖或腺嘌呤上,合成了四个配合物。这些铂配合物比钯类似物具有更高的细胞毒性,对各种实体瘤细胞,包括顺铂耐药细胞和某些 B 细胞淋巴瘤和 CLL 的细胞,具有低个位数微摩尔的 IC 值,这可能是由于铂配合物的细胞摄取率高十倍。然而,钯配合物更容易与分离的小牛胸腺 DNA 相互作用。有趣的是,与氟达拉滨相比,铂配合物对癌细胞的选择性要高得多。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d395/10343763/d2e163567329/molecules-28-05173-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d395/10343763/2283e9213bb4/molecules-28-05173-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d395/10343763/7565169853c7/molecules-28-05173-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d395/10343763/d2e163567329/molecules-28-05173-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d395/10343763/2283e9213bb4/molecules-28-05173-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d395/10343763/7565169853c7/molecules-28-05173-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d395/10343763/d2e163567329/molecules-28-05173-g002.jpg

相似文献

1
Palladium and Platinum Complexes of the Antimetabolite Fludarabine with Vastly Enhanced Selectivity for Tumour over Non-Malignant Cells.具有代谢拮抗作用的氟达拉滨与钯和铂的配合物,对肿瘤细胞具有显著高于非恶性细胞的选择性。
Molecules. 2023 Jul 2;28(13):5173. doi: 10.3390/molecules28135173.
2
Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.钯(II)和铂(II)与4,7-二氢-5-甲基-7-氧代[1,2,4]三唑并[1,5-a]嘧啶形成的有机金属配合物。铂化合物的抗肿瘤活性。
Inorg Chem. 2008 Jun 2;47(11):4490-505. doi: 10.1021/ic701873b. Epub 2008 Apr 30.
3
Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.利妥昔单抗:用于非霍奇金淋巴瘤和慢性淋巴细胞白血病的综述
Drugs. 2003;63(8):803-43. doi: 10.2165/00003495-200363080-00005.
4
Synthesis, characterization, and cytotoxic studies of alpha-diimine/1,2-diamine platinum(II) and palladium(II) complexes of selenite and tellurite and binding of some of these complexes to DNA.
J Inorg Biochem. 1991 Dec;44(4):239-47. doi: 10.1016/0162-0134(91)84029-9.
5
Evaluation of in vitro cytotoxicity and hepatotoxicity of platinum(II) and palladium(II) oxalato complexes with adenine derivatives as carrier ligands.评价以腺嘌呤衍生物作为载体配体的铂(II)和钯(II)草酸盐配合物的体外细胞毒性和肝毒性。
J Inorg Biochem. 2010 Oct;104(10):1130-2. doi: 10.1016/j.jinorgbio.2010.07.002. Epub 2010 Jul 31.
6
Diimine platinum(II) and palladium(II) complexes of dithiocarbamate derivative as potential antitumor agents: synthesis, characterization, cytotoxicity, and detail dna-binding studies.二硫代氨基甲酸盐衍生物的二亚胺铂(II)和钯(II)配合物作为潜在的抗肿瘤剂:合成、表征、细胞毒性及详细的DNA结合研究
J Biomol Struct Dyn. 2009 Apr;26(5):575-86. doi: 10.1080/07391102.2009.10507273.
7
Effects of histidin-2-ylidene vs. imidazol-2-ylidene ligands on the anticancer and antivascular activity of complexes of ruthenium, iridium, platinum, and gold.组氨酸-2-叶立德与咪唑-2-叶立德配体对钌、铱、铂和金配合物的抗癌和抗血管生成活性的影响
J Inorg Biochem. 2016 Oct;163:221-228. doi: 10.1016/j.jinorgbio.2016.07.021. Epub 2016 Jul 27.
8
Biological activity of palladium(II) and platinum(II) complexes of the acetone Schiff bases of S-methyl- and S-benzyldithiocarbazate and the X-ray crystal structure of the [Pd(asme)2] (asme=anionic form of the acetone Schiff base of S-methyldithiocarbazate) complex.S-甲基和S-苄基二硫代氨基甲酸盐丙酮席夫碱的钯(II)和铂(II)配合物的生物活性以及[Pd(asme)2](asme = S-甲基二硫代氨基甲酸盐丙酮席夫碱的阴离子形式)配合物的X射线晶体结构
J Inorg Biochem. 2002 Nov 25;92(3-4):141-8. doi: 10.1016/s0162-0134(02)00559-7.
9
Mixed ligand complexes of platinum(II) and palladium(II) with cytokinin-derived compounds Bohemine and Olomoucine: X-ray structure of [Pt(BohH+-N7)Cl(3)].9/5H2O [Boh=6-(benzylamino)-2-[(3-(hydroxypropyl)-amino]-9-isopropylpurine, Bohemine].铂(II)和钯(II)与细胞分裂素衍生化合物波希米宁和奥洛莫辛的混合配体配合物:[Pt(BohH⁺-N7)Cl(3)].9/5H2O [Boh = 6-(苄基氨基)-2-[(3-(羟丙基)-氨基]-9-异丙基嘌呤,波希米宁]的X射线结构
J Inorg Biochem. 2003 Apr 1;94(4):307-16. doi: 10.1016/s0162-0134(03)00051-5.
10
Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphoma.
Ann Oncol. 1994;5 Suppl 2:79-83. doi: 10.1093/annonc/5.suppl_2.s79.

引用本文的文献

1
From molecule to medicine: introducing emerging strategies to synthesize potent anticancer purine scaffolds.从分子到药物:介绍合成强效抗癌嘌呤支架的新兴策略。
RSC Adv. 2025 Jun 25;15(27):21604-21638. doi: 10.1039/d5ra02893k. eCollection 2025 Jun 23.
2
Purine Scaffold in Agents for Cancer Treatment.癌症治疗药物中的嘌呤骨架
ACS Omega. 2025 Apr 29;10(18):18170-18183. doi: 10.1021/acsomega.5c00340. eCollection 2025 May 13.
3
Exploration of novel 6,8,9-trisubstituted purine analogues: synthesis, in vitro biological evaluation, and their effect on human cancer cells.

本文引用的文献

1
Revisiting the anticancer properties of phosphane(9-ribosylpurine-6-thiolato)gold(I) complexes and their 9H-purine precursors.重新探讨膦(9-核糖基嘌呤-6-硫醇)金(I)配合物及其 9H-嘌呤前体的抗癌特性。
J Biol Inorg Chem. 2022 Dec;27(8):731-745. doi: 10.1007/s00775-022-01968-x. Epub 2022 Oct 16.
2
Synthesis of Platinum(II) N-Heterocyclic Carbenes Based on Adenosine.基于腺苷的铂(II)氮杂环卡宾的合成。
Molecules. 2021 Sep 4;26(17):5384. doi: 10.3390/molecules26175384.
3
Cancer statistics for the year 2020: An overview.2020年癌症统计数据概述。
新型6,8,9-三取代嘌呤类似物的探索:合成、体外生物学评价及其对人癌细胞的影响。
Turk J Chem. 2023 Dec 4;48(1):108-115. doi: 10.55730/1300-0527.3643. eCollection 2024.
Int J Cancer. 2021 Apr 5. doi: 10.1002/ijc.33588.
4
Design, Synthesis and In Vitro Cytotoxic Activity of New 6,9-Disubstituted Purine Analogues.新型 6,9-取代嘌呤类似物的设计、合成及体外细胞毒性活性。
Acta Chim Slov. 2020 Mar;67(1):70-82.
5
Guided Antitumoural Drugs: (Imidazol-2-ylidene)(L)gold(I) Complexes Seeking Cellular Targets Controlled by the Nature of Ligand L.导向抗肿瘤药物:(咪唑-2-亚基)(L)金(I)配合物,其通过配体L的性质寻找细胞靶点
Chemistry. 2021 Mar 12;27(15):5003-5010. doi: 10.1002/chem.202005451. Epub 2021 Feb 8.
6
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.慢性淋巴细胞白血病:ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2021 Jan;32(1):23-33. doi: 10.1016/j.annonc.2020.09.019. Epub 2020 Oct 19.
7
Treatment of Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病的治疗
N Engl J Med. 2020 Jul 30;383(5):460-473. doi: 10.1056/NEJMra1908213.
8
N-Heterocyclic Carbenes Derived from Guanosine: Synthesis and Evidences of Their Antiproliferative Activity.源自鸟苷的氮杂环卡宾:其抗增殖活性的合成与证据
ACS Omega. 2018 Nov 30;3(11):15653-15656. doi: 10.1021/acsomega.8b02387. Epub 2018 Nov 16.
9
Fludarabine-resistance associates with ceramide metabolism and leukemia stem cell development in chronic lymphocytic leukemia.氟达拉滨耐药与慢性淋巴细胞白血病中的神经酰胺代谢及白血病干细胞发育相关。
Oncotarget. 2018 Sep 4;9(69):33124-33137. doi: 10.18632/oncotarget.26043.
10
Targeting transcription-coupled nucleotide excision repair overcomes resistance in chronic lymphocytic leukemia.靶向转录耦联核苷酸切除修复克服慢性淋巴细胞白血病的耐药性。
Leukemia. 2017 May;31(5):1177-1186. doi: 10.1038/leu.2016.294. Epub 2016 Oct 24.